Alessandro Rambaldi MD

Alessandro Rambaldi, MD, is a Full Professor of Hematology at the Department of Oncology and Hematology at the University of Milan, Italy. Following his medical degree, he was an Associate in Pathology at the Dana Farber Cancer Institute, Boston, USA. Since 2006 he is the Director of the Hematology and Bone Marrow Transplant Unit at the Ospedale Papa Giovanni XXIII, Bergamo, Italy. He is a member of the American Society of Hematology (ASH), the European Hematology Association (EHA), and the European Blood and Marrow Transplant Group (BMT). From 2010 he served JACIE as Vice Chair and Chair from 2010 to 2015. From 2011 to 2014 he was President of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Alessandro's scientific interest ranges from translational research to academic clinical trials in which he pioneered the integration of molecular evaluation of minimal residual disease in the treatment strategy of adult patients with acute lymphoblastic leukemia and non-Hodgkin’s lymphomas.  He also led several trials in the field of acute leukemia, lymphomas chronic myeloproliferative neoplasms, and allogeneic stem cell transplantation. A current special research interest is the development of innovative cellular therapies for the treatment of leukemia relapse after allogeneic stem cell transplantation. Prof. Alessandro Rambaldi has published more than 600 manuscripts in peer-reviewed journals such as the Journal of Clinical Oncology, Lancet Oncology, Lancet Haematology, Blood, Leukemia, Haematologica, and many others for which he routinely serves as a referee.